Free Trial
→ He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (From The Oxford Club) (Ad)tc pixel Free CADL Stock Alerts

Candel Therapeutics (CADL) SEC Filings & 10K Form

Candel Therapeutics logo
$4.97 -0.13 (-2.55%)
Closing price 04:00 PM Eastern
Extended Trading
$5.03 +0.06 (+1.19%)
As of 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Candel Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/24/2025
11:15 PM		Candel Therapeutics (Filer)
Form EFFECT
08/21/2025
3:30 PM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2025
7:39 AM		Candel Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/14/2025
7:07 AM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2025
7:10 AM		Candel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2025
3:30 PM		Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
3:30 PM		Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
8:55 AM		ACORN BIOVENTURES, L.P. (Filed by)
Candel Therapeutics (Subject)
Form SCHEDULE 13G
06/26/2025
7:30 AM		Candel Therapeutics (Issuer)
PAPA JOSEPH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
7:30 AM		Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
7:30 AM		Candel Therapeutics (Issuer)
Nabel Gary J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
7:30 AM		Candel Therapeutics (Issuer)
Loggia Nicoletta (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
7:30 AM		Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
7:30 AM		Candel Therapeutics (Issuer)
Martell Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
7:30 AM		Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
7:30 AM		Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
7:30 AM		Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:30 PM		Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
8:20 AM		Candel Therapeutics (Filer)
Form 424B5
06/24/2025
8:27 AM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
7:15 AM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
7:30 AM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
7:32 AM		Candel Therapeutics (Issuer)
PAPA JOSEPH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
7:33 AM		Candel Therapeutics (Issuer)
Nguyen Diem (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
7:33 AM		Candel Therapeutics (Issuer)
Nabel Gary J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
7:34 AM		Candel Therapeutics (Issuer)
Martell Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
7:35 AM		Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
7:36 AM		Candel Therapeutics (Issuer)
Loggia Nicoletta (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
7:37 AM		Candel Therapeutics (Issuer)
Gaeta Renee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
7:38 AM		Benz Edward J. JR (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:31 PM		Candel Therapeutics (Issuer)
Radhakrishnan Maha (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2025
7:11 AM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025
7:10 AM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2025
4:12 PM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
7:30 AM		Candel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2025
7:15 AM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
3:15 PM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
8:57 PM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
3:35 PM		Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4/A
03/20/2025
3:35 PM		Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:36 PM		Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:36 PM		Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
3:12 PM		Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:28 PM		Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:29 PM		Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:29 PM		Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2025
3:29 PM		Candel Therapeutics (Subject)
Schoch Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2025
3:29 PM		Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
3:45 PM		Candel Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2025
12:35 PM		Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:15 AM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:32 PM		Candel Therapeutics (Subject)
Northpond Ventures, LP (Filed by)
Form SCHEDULE 13G/A
02/14/2025
3:30 PM		Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM		Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM		Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM		Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM		Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
5:25 AM		Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:09 PM		Candel Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SCHEDULE 13G/A
02/07/2025
9:18 AM		Candel Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
02/07/2025
9:03 AM		Candel Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G
01/15/2025
7:30 AM		Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
7:30 AM		Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
7:30 AM		Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
7:30 AM		Candel Therapeutics (Subject)
Schoch Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
7:30 AM		Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
7:05 AM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:30 PM		Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:30 PM		Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:30 PM		Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:30 PM		Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:30 PM		Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:27 AM		Candel Therapeutics (Subject)
Schoch Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:27 AM		Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:28 AM		Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:28 AM		Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:29 AM		Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/30/2024
6:37 PM		Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
12:59 PM		Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:11 PM		Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
11:30 AM		Candel Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G
12/13/2024
5:12 PM		Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
4:30 PM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
3:36 PM		Candel Therapeutics (Filer)
Form 424B5
12/12/2024
3:55 PM		Candel Therapeutics (Filer)
Form 424B5
12/11/2024
6:45 AM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
5:44 PM		Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:46 PM		Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:47 PM		Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:48 PM		Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:48 PM		Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
8:12 AM		Barone Francesca (Reporting)
Candel Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
8:13 AM		Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
8:15 AM		Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
8:17 AM		Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
5:24 PM		Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
2:07 PM		Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
7:30 AM		Candel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
7:15 AM		Candel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:58 PM		Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CADL) was last updated on 9/9/2025 by MarketBeat.com Staff
From Our Partners
Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...
Stansberry Research | Sponsoredtc pixel
Buffett, Gates and Bezos Dumping Stocks
The world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...
Banyan Hill Publishing | Sponsoredtc pixel
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...
InvestorPlace | Sponsoredtc pixel
2013 Bitcoin miner reveals his trading system (free)
While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...
Crypto Swap Profits | Sponsoredtc pixel
Forget Tesla — This Tiny AI Stock Is Musk’s Real Play
While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...
Behind the Markets | Sponsoredtc pixel
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...
Brownstone Research | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Why This Critical Minerals Explorer Caught Rio Tinto’s Eye
As U.S. defense spending crosses $1 trillion, drones, hypersonics, and next-gen aerospace are taking center st...
The Tomorrow Investor | Sponsoredtc pixel